ACE Inhibitor-Induced Acute Kidney Injury in Bilateral Renal Artery Stenosis
Nephrology
Illness script · Nephrology
ACE Inhibitor-Induced Acute Kidney Injury in Bilateral Renal Artery Stenosis
Precipitous GFR drop occurring when ACEi/ARB removes the angiotensin II-mediated efferent arteriolar tone that sustains filtration pressure in bilateral RAS.
This illness script for ACE Inhibitor-Induced Acute Kidney Injury in Bilateral Renal Artery Stenosis covers predisposing factors, classic presentation, mechanism, workup, management, and the clinical pivots that separate it from look-alikes—written for USMLE Step 1 and clerkship reasoning.
01
Predisposing factors
- Elderly patients with diffuse atherosclerosis (most common cause of RAS)
- Refractory hypertension requiring ≥3 antihypertensives
- Peripheral artery disease, CAD, aortic disease
- Bilateral RAS or unilateral RAS with solitary/dominant kidney
- Smoking, diabetes, dyslipidemia — shared atherosclerotic risk
- Fibromuscular dysplasia in younger women (rarer cause of RAS)
02
Presentation
- Creatinine rise >30–50% within days to weeks of starting ACEi or ARB
- Underlying refractory hypertension (classic setup in vignette)
- Audible epigastric/flank bruit on exam
- Flash pulmonary edema is a pathognomonic presentation of bilateral RAS
- Asymmetric kidney sizes on imaging (atrophic kidney from chronic ischemia)
- Often oliguria; may be asymptomatic until labs checked
03
Pathophysiology
- Bilateral RAS → reduced renal perfusion → high renin-angiotensin II state
- Ang II selectively constricts efferent arteriole → maintains intraglomerular pressure and GFR
- ACEi/ARB blocks Ang II → efferent arteriole dilates → intraglomerular pressure collapses
- Both kidneys are dependent on this compensatory mechanism → GFR falls precipitously
04
Diagnostics
- First-line screen: renal duplex Doppler ultrasound (non-invasive, evaluates flow velocity)
- Gold standard: CT or MR angiography; catheter angiography if intervention planned
- Key trigger: ≥50% creatinine rise shortly after starting ACEi should prompt RAS workup
- Renal ultrasound: size asymmetry >1.5 cm between kidneys is a clue
- BMP: elevated BUN/Cr; hyperkalemia may co-occur with ACEi use
05
Management
- Immediately discontinue ACEi or ARB — creatinine typically recovers
- ACEi/ARBs are absolutely contraindicated in bilateral RAS or RAS in solitary kidney
- Revascularization: percutaneous transluminal angioplasty ± stenting (preferred for atherosclerotic RAS)
- Alternative antihypertensives: dihydropyridine calcium channel blockers (amlodipine), beta-blockers
- Surgical revascularization reserved for failed or anatomically unsuitable endovascular cases
06
Clinical pivots
How to separate this script from the look-alikes that show up on exams and on the wards.
Unilateral RAS (normal contralateral kidney)
Contralateral kidney compensates → ACEi rarely causes significant AKI; bilateral involvement is the critical distinction.
Prerenal AKI from volume depletion
Volume depletion responds to IV fluids; ACEi-induced bilateral RAS AKI does not improve with fluids — only ACEi removal helps.
NSAID-induced AKI
NSAIDs impair afferent arteriolar dilation; temporal link to NSAID use rather than ACEi, no RAS on imaging.
Renal atheroembolism
Livedo reticularis, eosinophilia, low complement after vascular procedure or anticoagulation — not seen with ACEi-precipitated RAS AKI.
Keep reading
Full libraryEducational use only. This illness script is a study framework, not medical advice. Confirm decisions with current guidelines and your clinical supervisors.